Clinical Trial Update: Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells Delivered in Patients With Renal Failure [NA]

View source ↗

Summary

The trial evaluating autologous adipose-derived stromal cells in patients with renal failure has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure

Drugs mentioned

• Autologous adipose-derived stromal cells (adipose-derived stromal cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Renal Failure | NA | Status: WITHDRAWN